Back to Trades
Other4
Seaport Therapeutics, Inc.
SPTX
Total Value
$0
Company Information
- Company Name
- Seaport Therapeutics, Inc.
- Ticker Symbol
- SPTX
- CIK
- 0002042347
Insider Information
- Name
- HEALY JAMES
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- May 4, 2026
- Transaction Date
- May 4, 2026
- Accession Number
- 0001193125-26-204494
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | 1,927,159 | — | C | — |
| May 4, 2026 | Common Stock | 804,379 | — | C | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| May 4, 2026 | Derivative | 6,052,631 | — | C | — |
| May 4, 2026 | Derivative | 2,526,315 | — | C | — |
Footnotes
- (F1)Each share of Series A-2 and Series B Preferred Stock (collectively, the "Preferred Stock") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date.
- (F2)These shares are directly held by Sofinnova Venture Partners XI, L.P. ("SVP XI"). Sofinnova Management XI, L.P. ("SM XI LP") is the general partner of SVP XI, and Sofinnova Management XI, L.L.C. ("SM XI") is the general partner of SM XI LP. The Reporting Person is a managing member of SM XI and may be deemed to share voting and investment discretion with respect to securities directly held by SVP XI. The Reporting Person disclaims beneficial ownership of the securities directly held by SVP XI. This report shall not be construed as an admission that he is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, except to the extent of his pecuniary interest therein, if any.